12/19/2024 4:01 PM | Mersana Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 4:45 PM | Mersana Therapeutics (Subject) Nextech Crossover I GP S.a r.l. (Filed by)
| Form SC 13G/A | |
11/14/2024 5:01 AM | BALYASNY ASSET MANAGEMENT L.P. (Filed by) Mersana Therapeutics (Subject)
| Form SC 13G/A | |
11/13/2024 7:50 AM | Mersana Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024 6:27 AM | Mersana Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/29/2024 3:43 PM | Bala Mohan (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/29/2024 3:26 PM | Bala Mohan (Reporting) Mersana Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
10/15/2024 5:55 AM | Mersana Therapeutics (Subject) SILVERARC CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
10/07/2024 4:46 PM | Lowinger Timothy B (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/07/2024 4:47 PM | Mandelia Ashish (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/07/2024 4:47 PM | Bala Mohan (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/07/2024 4:48 PM | Carvajal Alejandra (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/07/2024 4:48 PM | DeSchuytner Brian (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/07/2024 4:18 PM | Lowinger Timothy B (Reporting) Mersana Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/07/2024 4:18 PM | DeSchuytner Brian (Reporting) Mersana Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/07/2024 4:19 PM | Carvajal Alejandra (Reporting) Mersana Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/07/2024 4:20 PM | Bala Mohan (Reporting) Mersana Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024 7:08 PM | Alleva Lawrence M (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2024 4:06 PM | Huber Martin H. Jr. (Reporting) Mersana Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2024 4:08 PM | Huber Martin H. Jr. (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/13/2024 7:59 AM | Mersana Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024 6:18 AM | Mersana Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/12/2024 4:31 PM | Hack Andrew A. F. (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2024 3:49 PM | Alleva Lawrence M (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2024 3:51 PM | Dere Willard H (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2024 3:51 PM | Diaz Allene M. (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2024 3:52 PM | Hege Kristen (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2024 3:53 PM | Mersana Therapeutics (Issuer) MOTT DAVID M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2024 3:54 PM | Mersana Therapeutics (Issuer) Protopapas Anna (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2024 7:26 AM | Mersana Therapeutics (Subject) Nextech Crossover I GP S.a r.l. (Filed by)
| Form SC 13G | |
05/09/2024 11:15 PM | Mersana Therapeutics (Filer)
| Form EFFECT | |
05/09/2024 4:06 PM | Mersana Therapeutics (Filer)
| Form 424B5 | |
05/09/2024 8:00 AM | Mersana Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024 6:10 AM | Mersana Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/26/2024 5:25 AM | Mersana Therapeutics (Filer)
| Form ARS | |
04/26/2024 5:02 AM | Mersana Therapeutics (Filer)
| Form DEF 14A | |
04/26/2024 5:04 AM | Mersana Therapeutics (Filer)
| Form DEFA14A | |
04/03/2024 7:14 PM | Alleva Lawrence M (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 3:05 PM | Mersana Therapeutics (Filer)
| Form POS AM | |
02/28/2024 7:49 AM | Mersana Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/28/2024 7:43 AM | Mersana Therapeutics (Filer)
| Form POSASR | |
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad) Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days.
It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year.
This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now |
02/28/2024 6:07 AM | Mersana Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 7:56 PM | Mersana Therapeutics (Subject) Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024 7:43 PM | Mersana Therapeutics (Subject) SILVERARC CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G | |
02/14/2024 5:55 PM | Mersana Therapeutics (Subject) ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024 8:20 AM | Avoro Capital Advisors LLC (Filed by) Mersana Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024 6:22 AM | BALYASNY ASSET MANAGEMENT L.P. (Filed by) Mersana Therapeutics (Subject)
| Form SC 13G | |
01/22/2024 12:36 PM | Mersana Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/17/2024 4:16 PM | Bala Mohan (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 4:18 PM | DeSchuytner Brian (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 4:18 PM | Carvajal Alejandra (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 4:19 PM | Huber Martin H. Jr. (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 4:19 PM | Lowinger Timothy B (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 4:20 PM | Mandelia Ashish (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 4:21 PM | Mersana Therapeutics (Issuer) MISRA TUSHAR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 4:21 PM | Mersana Therapeutics (Issuer) Protopapas Anna (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 8:12 PM | Mersana Therapeutics (Subject) Protopapas Anna (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024 8:13 PM | DeSchuytner Brian (Reporting) Mersana Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024 8:13 PM | Lowinger Timothy B (Reporting) Mersana Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024 8:14 PM | Bala Mohan (Reporting) Mersana Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024 3:42 PM | Mersana Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/05/2024 7:06 AM | Mersana Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 3:14 PM | Hege Kristen (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:15 PM | Alleva Lawrence M (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |